← Back to Search

Geriatric Assessment for Elderly with Breast Cancer

N/A
Waitlist Available
Led By Hyman Muss, MD
Research Sponsored by UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 year
Awards & highlights

Study Summary

This trial is testing whether conducting a survey called the geriatric assessment with elderly breast cancer patients can help identify symptoms and issues earlier. The hope is that this will lead to better patient outcomes.

Who is the study for?
This trial is for women aged 70 or older who have recently finished primary treatment for early-stage breast cancer. Participants must be able to read English and provide informed consent. Women with dementia, altered mental status, or conditions affecting their ability to consent are excluded.Check my eligibility
What is being tested?
The study uses a geriatric assessment survey post-treatment to identify issues in elderly breast cancer survivors. The results guide the medical team in making specialist referrals. It aims to see if these steps can fit into regular clinic visits and if patients follow through on recommendations.See study design
What are the potential side effects?
Since this trial involves assessments and referrals rather than direct medical interventions, there are no typical medication side effects; however, participants may experience stress or anxiety from the evaluation process.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of Participants who agree to referral
Secondary outcome measures
Percentage of referral acceptance among participants with Nutrition deficits, as identified by the geriatric assessment
Percentage of referral acceptance among participants with cognition deficits, as identified by the geriatric assessment
Percentage of referral acceptance among participants with comorbidity deficits, as identified by the geriatric assessment
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Geriatric AssessmentExperimental Treatment1 Intervention
Participants fill out the geriatric assessment during a clinic visit and receive recommendations based on results

Find a Location

Who is running the clinical trial?

Breast Cancer Research FoundationOTHER
69 Previous Clinical Trials
137,703 Total Patients Enrolled
41 Trials studying Breast Cancer
130,413 Patients Enrolled for Breast Cancer
UNC Lineberger Comprehensive Cancer CenterLead Sponsor
351 Previous Clinical Trials
88,232 Total Patients Enrolled
51 Trials studying Breast Cancer
27,886 Patients Enrolled for Breast Cancer
Hyman Muss, MDPrincipal InvestigatorUNC Lineberger Comprehensive Cancer Center
10 Previous Clinical Trials
4,009 Total Patients Enrolled
5 Trials studying Breast Cancer
709 Patients Enrolled for Breast Cancer

Media Library

Breast Cancer Research Study Groups: Geriatric Assessment

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities available to join this trial?

"Judging from the latest clinicaltrials.gov data, this experiment is no longer searching for participants. Initially posted on March 12th 2020 and last modified on May 17th 2022, it has since concluded its recruitment process; however, there are an abundance of other studies actively recruiting at present with a total of 2601 trials accepting patients."

Answered by AI
~21 spots leftby Jun 2025